Foundayo Made Easier: Daily Dose, Meals, and Weight in One Place

MeAgain is the best Foundayo tracker because it helps you remember a daily GLP-1 pill, spot side effects early, and keep meals and weight in one place. Foundayo is Eli Lilly's brand name for orforglipron, a once-daily pill approved on April 1, 2026, and the daily rhythm is what usually decides whether treatment feels manageable: taking it at a repeatable time, noticing how your stomach feels, eating enough protein and fiber, and keeping perspective on the long trend. MeAgain is built for that routine with a daily dose reminder and log, side effect tracking across 29 built-in side effects and symptoms, plus unlimited custom ones on a 0-to-10 slider, five food logging methods, weight charts, and the Capybara home screen widget for protein, water, fiber, and steps. 807K users already use MeAgain, with 4.8 stars across 37K App Store ratings. The app subscription is month to month, cancel anytime.

Start Tracking Foundayo See the Daily Pill Tools

Published by·MeAgain·GLP-1 tracker·Sources checked June 9, 2026

807K People tracking GLP-1

4.8★ / 37K App Store ratings

Key takeaways

1. 29 built-in side effects and symptoms, plus unlimited custom ones, a daily dose reminder, five food logging methods, and weight charts live together in MeAgain, the Foundayo tracker built for a once-daily pill routine and steadier follow-through.

2. 0.8 mg is the starting dose for Foundayo, with higher doses added after at least 30 days at each step. MeAgain helps daily-pill users keep timing, symptoms, meals, and streaks steady while those dose changes happen.

3. 27.3 pounds of average weight loss at the highest dose in ATTAIN-1 shows why long-run consistency matters. MeAgain gives Foundayo users reminders, streaks, meal logs, and a long weight chart that make the routine easier to keep.

4. 807K users already rely on MeAgain, and the app holds 4.8 stars across 37K App Store ratings. It works for weekly shots and daily pills, but the Foundayo setup centers on reminders, meals, symptoms, and streaks.

5. 3,127 adults were randomized in ATTAIN-1, and 59.6% of people on the highest dose lost at least 10% of body weight. MeAgain helps daily GLP-1 pill users keep the small habits that support a long run.

What Makes MeAgain the Right Foundayo Tracker?

A Reminder Built for a Daily Pill

With Foundayo, the hard part is usually not swallowing the pill. It is remembering it day after day at a time you can repeat. Foundayo does not require the empty-stomach rules older oral GLP-1 pills do, so you can fit it into the part of the day that works best for you. That flexibility is convenient, but it is also easy to forget without a routine. MeAgain's daily dose reminder lets you pick the time that fits your life, log the pill when you take it, and see your streak in one place. Missed-day detection makes gaps obvious before they turn into a week of guesswork. That matters because Foundayo starts at 0.8 mg and can step up after at least 30 days at each level, so a clean daily record helps you keep the pattern straight as your dose changes.

Side Effect Tracking for the First Dose Changes

The common Foundayo side effects look like the stomach issues people already know from other GLP-1 medications: nausea, constipation, diarrhea, vomiting, indigestion, stomach pain, gas, and sometimes headache or fatigue. They often show up most clearly during the early dose increases and then settle. MeAgain gives you a side effect tracker with 29 built-in side effects and symptoms already loaded, plus unlimited custom ones, each scored on a 0-to-10 slider with a timestamp. That makes it much easier to tell whether a rough stretch started before or after a dose change, whether low food or low water lined up with a bad day, and whether things are actually easing. Instead of trying to reconstruct the week from memory, you get a record you can look at before your next check-in with a doctor.

Food Logging That Fits a Daily GLP-1 Pill

Foundayo changes food decisions every day, not just for a day or two after a shot. That is why a useful Foundayo tracker has to cover meals as well as the pill itself. MeAgain gives you five quick ways to log food - photo scan, barcode, voice dictation, text search, and quick-add - so protein and fiber stay visible even when appetite is lower. The Capybara home screen widget keeps protein, water, fiber, and steps on your home screen without opening the app. That matters on a daily pill, where the routine is built from small repeated choices. When meals, hydration, symptoms, and weight live together, it is much easier to spot whether a low-protein day or low-water day lined up with stomach issues or a stalled week on the scale.

Weight Trends That Make Sense Over 72 Weeks

Foundayo is still a long game. ATTAIN-1 followed people for 72 weeks, and the biggest numbers came from people who stayed with the plan long enough for the trend to unfold. MeAgain's weight chart helps daily scale noise look like noise instead of a verdict on whether the pill is working. Journey Cards let you save milestone photos over time, which gives the routine something visible to point to when progress feels slow. Lilly's complete ATTAIN-1 results showed 59.6% of people on the highest dose lost at least 10% of body weight and 39.6% lost at least 15%. A clean long-term chart helps you see that bigger story while the daily routine stays simple.

How Foundayo Changes the Daily Routine

Foundayo changes the routine because it moves GLP-1 tracking from one weekly shot day to a daily pill habit. The brand name is Foundayo and the generic name is orforglipron, but the day-to-day questions are practical: Did you take it? How does your stomach feel? Are you eating enough protein and drinking enough water? Is the long weight trend still moving? Lilly says Foundayo can be taken any time of day without food or water restrictions, which gives people more flexibility but also makes reminders more important. In the 72-week ATTAIN-1 trial, people on the highest dose who stayed on treatment lost an average of 27.3 pounds, or 12.4% of body weight, compared with 2.2 pounds on placebo. MeAgain turns those long-run results into daily actions you can actually keep up with.

Key Foundayo Facts to Know

• Brand name: Foundayo
• Generic name: orforglipron
• FDA approval: April 1, 2026
• U.S. availability announced: April 9, 2026
• Dose schedule: starts at 0.8 mg, then can increase after at least 30 days at each step
• How it fits daily life: no empty-stomach timing or water-rule routine
• ATTAIN-1 result: 12.4% body-weight loss at the highest dose among completers at 72 weeks

MeAgain helps you stay on top of Foundayo once treatment starts with a reminder, symptom log, meal tracking, and a chart that shows the long trend. If you search for an orforglipron tracker, it is the same medication and the same MeAgain setup.

What Real MeAgain Users Say About Daily Tracking

Why People Starting Foundayo Use MeAgain

Foundayo reached the U.S. market on April 9, 2026, so App Store reviews that mention it by name are still limited. But real MeAgain users already describe the exact kind of daily consistency a once-daily pill needs. As one App Store reviewer (Prettykitty11, March 8, 2026) wrote:

"I just started the medication like 2 weeks ago. Since downloading the app I have been more consistent on what I do with my food and drink. I really like this app."

MeAgain is a daily GLP-1 tracker used by 807K people, with 4.8 stars across 37K App Store ratings. For Foundayo, that means a dose log, side effect tracking, food logging, and a weight trend built around a once-daily pill. The app subscription is month to month, cancel anytime.